Epiminder is a neurotechnology company developing an implantable EEG-based monitoring system designed for long-term tracking of epileptic seizures. The company focuses on addressing limitations of short-duration EEG and patient-reported seizure diaries by enabling continuous, objective data collection.

Its core technology, the Minder system, consists of a minimally invasive sub-scalp implant paired with external wearable and cloud-based analytics. The system continuously records brain activity and applies automated analysis to detect and classify seizures, supporting accurate longitudinal monitoring.

Epiminder’s technology is intended for clinical use in epilepsy diagnosis and management, including treatment optimization and therapy evaluation. The company positions its platform as a diagnostic and monitoring infrastructure that complements clinical workflows rather than a therapeutic neuromodulation device.